Request for Information - Oligonucleotides Onshoring

not constitute a sourcing exercise nor will the Authority pay any costs incurred in the preparation of a response to this RFI. 3. The UK Health Security Agency's (UKHSA) key objectives for this RFI are: a. understand the ability of the marketplace to fulfil its requirements; b. refine the scope

of the requirements to best align to the marketplace; and c. inform the Authority's chosen route to market to best enable competition Description of Scope of Requirements: UKHSA sees access to oligonucleotide manufacturers as key to